Essential role of STX6 in esophageal squamous cell carcinoma growth and migration

Biochemical and Biophysical Research Communications

Volumn 472, Issue 1, 2016, Pages 60-67

  Du, Jin ^a,b   Liu, Xiang ^a   Wu, Yanhu ^a   Zhu, Jinfu ^a   Tang, Yihu ^a  

^a THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cell growth and migration; ESCC; Integrin trafficking; p53; STX6

Indexed keywords

INTEGRIN; PROTEIN P53; SYNTAXIN; SYNTAXIN 6; UNCLASSIFIED DRUG; ALPHA3 INTEGRIN; SMALL INTERFERING RNA; TP53 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER GROWTH; CANCER SIZE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; ESOPHAGEAL CANCER CELL LINE; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; UPREGULATION; AGED; ANTAGONISTS AND INHIBITORS; CELL MOTION; ESOPHAGUS TUMOR; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA3; MALE; MIDDLE AGED; QA-SNARE PROTEINS; RNA, SMALL INTERFERING; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84960438547     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.02.061     Document Type: Article

References (24)

1. A. Pennathur, M.K. Gibson, B.A. Jobe, and J.D. Luketich Oesophageal carcinoma Lancet 381 9864 2013 Feb 2 400 412
2. Y. Zhang Epidemiology of esophageal cancer World J. Gastroenterol. 19 34 2013 Sep 14 5598 5606
3. N.S. Sakai, E. Samia-Aly, M. Barbera, and R.C. Fitzgerald A review of the current understanding and clinical utility of miRNAs in esophageal cancer Semin. Cancer Biol. 23 6 Pt B 2013 Dec 512 521
4. L. Hong, Y. Han, and L. Brain Epidermal growth factor receptor: an important target in esophageal cancer Expert Opin. Ther. Targets 17 10 2013 Oct 1179 1185
5. N. Engedal, and I.G. Mills Endosomal signaling and oncogenesis Methods Enzymol. 535 2014 179 200
6. I.R. Johnson, E.J. Parkinson-Lawrence, T. Shandala, R. Weigert, L.M. Butler, and D.A. Brooks Altered endosome biogenesis in prostate cancer has biomarker potential Mol. Cancer Res. 12 12 2014 Dec 1851 1862
7. C. Joffre, R. Barrow, L. Ménard, V. Calleja, I.R. Hart, and S. Kermorgant A direct role for Met endocytosis in tumorigenesis Nat. Cell Biol. 13 7 2011 Jun 5 827 837
8. J.B. Bock, H.T. Matern, A.A. Peden, and R.H. Scheller A genomic perspective on membrane compartment organization Nature 409 6822 2001 Feb 15 839 841
9. J.B. Bock, R.C. Lin, and R.H. Scheller A new syntaxin family member implicated in targeting of intracellular transport vesicles J. Biol. Chem. 271 30 1996 Jul 26 17961 17965
10. J.B. Bock, J. Klumperman, S. Davanger, and R.H. Scheller Syntaxin 6 functions in trans-Golgi network vesicle trafficking Mol. Biol. Cell. 8 7 1997 Jul 1261 1271
11. F. Mallard, B.L. Tang, T. Galli, D. Tenza, A. Saint-Pol, X. Yue, C. Antony, W. Hong, B. Goud, and L. Johannes Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform J. Cell Biol. 156 4 2002 Feb 18 653 664
12. R. Kuliawat, E. Kalinina, J. Bock, L. Fricker, T.E. McGraw, S.R. Kim, J. Zhong, R. Scheller, and P. Arvan Syntaxin-6 SNARE involvement in secretory and endocytic pathways of cultured pancreatic beta-cells Mol. Biol. Cell. 15 4 2004 Apr 1690 1701
13. V. Manickam, A. Tiwari, J.J. Jung, R. Bhattacharya, A. Goel, D. Mukhopadhyay, and A. Choudhury Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6 Blood 117 4 2011 Jan 27 1425 1435
14. Y. Zhang, L. Shu, and X. Chen Syntaxin 6, a regulator of the protein trafficking machinery and a target of the p53 family, is required for cell adhesion and survival J. Biol. Chem. 283 45 2008 Nov 7 30689 30698
15. K. Harms, S. Nozell, and X. Chen The common and distinct target genes of the p53 family transcription factors Cell Mol. Life Sci. 61 7-8 2004 Apr 822 842
16. K.A. Riggs, N. Hasan, D. Humphrey, C. Raleigh, C. Nevitt, D. Corbin, and C. Hu Regulation of integrin endocytic recycling and chemotactic cell migration by syntaxin 6 and VAMP3 interaction J. Cell Sci. 125 Pt 16 2012 Aug 15 3827 3839
17. C.D. Fichter, C. Herz, C. Münch, O.G. Opitz, M. Werner, and S. Lassmann Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells BMC Cell Biol. 12 2011 Apr 6 13
18. S. Kato, S.Y. Han, W. Liu, K. Otsuka, H. Shibata, R. Kanamaru, and C. Ishioka Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis Proc. Natl. Acad. Sci. U. S. A. 100 14 2003 Jul 8 8424 8429
19. S.M. Frisch, and E. Ruoslahti Integrins and anoikis Curr. Opin. Cell Biol. 9 5 1997 Oct 701 706
20. F. Lordick Current standard and trends in oesophageal cancer Eur. J. Cancer 47 Suppl. 3 2011 Sep S353 S354
21. M.A. Huber, N. Kraut, and H. Beug Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr. Opin. Cell Biol. 17 5 2005 Oct 548 558
22. H.L. Goel, J. Li, S. Kogan, and L.R. Languino Integrins in prostate cancer progression Endocr. Relat. Cancer 15 3 2008 Sep 657 664
23. W. Guo, and F.G. Giancotti Integrin signalling during tumour progression Nat. Rev. Mol. Cell Biol. 5 10 2004 Oct 816 826
24. P.T. Caswell, S. Vadrevu, and J.C. Norman Integrins: masters and slaves of endocytic transport Nat. Rev. Mol. Cell Biol. 10 12 2009 Dec 843 853